<p><strong>Bio-Techne 批准了與擬議合併相關的高管現金保留獎金。</strong></p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>保留協議提供$2,120,976 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$1,541,510 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$1,161,014 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$971,097 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$910,263 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
<p>原始 SEC 文件：BIO-TECHNE Corp [ TECH ] - 8-K -2026 年 6 月 25 日
<strong>免責聲明</strong></p>
<p>這是一個由人工智能生成的摘要。可能包含不準確的信息。請考慮與來源核實重要信息。請注意，此摘要僅基於提交給 SEC 的文件。</p>

TECH

<p>Bio-Techne 為五位指定高管，包括 Kim Kelderman 和 Jim Hippel，批准了現金保留獎金，以配合一項擬議中的合併。這些獎金的金額從約 91 萬美元到 210 萬美元不等，旨在鼓勵高管們在合併生效日期 2026 年 6 月 23 日之前繼續留任。獎金的支付取決於持續的僱傭關係或符合條件的終止，以及簽署解除協議</p>

<p><strong>Bio-Techne approved cash retention bonuses for named executive officers in connection with the contemplated merger.</strong></p>
<div class="lb-trans"><p><strong>Bio-Techne 批准了與擬議合併相關的高管現金保留獎金。</strong></p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Individual</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>Role</strong></td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
<td>Named executive officer</td>
</tr>
<tr>
<td><strong>Type of Change</strong></td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
<td>Retention bonus approved</td>
</tr>
<tr>
<td><strong>Effective Date</strong></td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
<td>June 23, 2026 (effective upon execution of Merger Agreement)</td>
</tr>
<tr>
<td><strong>Reason</strong></td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
<td>To encourage retention and continued performance until the Effective Time</td>
</tr>
<tr>
<td><strong>Replacement Info</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
<tr>
<td><strong>Background Details</strong></td>
<td>Retention agreement provides $2,120,976 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $1,541,510 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $1,161,014 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $971,097 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
<td>Retention agreement provides $910,263 lump sum; payable on Vesting Date subject to employment or Qualifying Termination and release execution</td>
</tr>
<tr>
<td><strong>Board/Committee Role Changes</strong></td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
<td>Not disclosed</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>個人</strong></td>
<td>Kim Kelderman</td>
<td>Jim Hippel</td>
<td>William Geist</td>
<td>Shane Bohnen</td>
<td>Steve Crouse</td>
</tr>
<tr>
<td><strong>角色</strong></td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
<td>高管</td>
</tr>
<tr>
<td><strong>變更類型</strong></td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
<td>批准保留獎金</td>
</tr>
<tr>
<td><strong>生效日期</strong></td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
<td>2026 年 6 月 23 日（在合併協議簽署後生效）</td>
</tr>
<tr>
<td><strong>原因</strong></td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
<td>鼓勵保留並持續表現直到生效時間</td>
</tr>
<tr>
<td><strong>替代信息</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
<tr>
<td><strong>背景詳情</strong></td>
<td>保留協議提供$2,120,976 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$1,541,510 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$1,161,014 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$971,097 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
<td>保留協議提供$910,263 一次性付款；在歸屬日期支付，需滿足僱傭或符合條件的終止及釋放執行</td>
</tr>
<tr>
<td><strong>董事會/委員會角色變更</strong></td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
<td>未披露</td>
</tr>
</tbody>
</table>
</div><p>Original SEC Filing: BIO-TECHNE Corp [ TECH ] - 8-K - Jun. 25, 2026
<strong>Disclaimer</strong></p>
<div class="lb-trans"><p>原始 SEC 文件：BIO-TECHNE Corp [ TECH ] - 8-K -2026 年 6 月 25 日
<strong>免責聲明</strong></p>
</div><p>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</p>
<div class="lb-trans"><p>這是一個由人工智能生成的摘要。可能包含不準確的信息。請考慮與來源核實重要信息。請注意，此摘要僅基於提交給 SEC 的文件。</p>
</div>

Bio-Techne 公司批准了 Kim Kelderman 和 Jim Hippel 的留任獎金